title: Conserved TCR beta chain usage in reactive arthritis; evidence for selection by a putative HLA-B27-associated autoantigen.
abstract: Previous work suggested that expanded CD8+ T-cell clones in the synovial fluid (SF) of HLA-B27+ patients with reactive arthritis (ReA) preferentially use the T-cell receptor variable region (TCRBV) 1, similar CDR3 sequences, and joining region (BJ) 2S3. To determine the range of conservation and disease-specificity of CDR3-sequences, we analyzed the TCRBV1-J2S3 repertoire from 33 healthy HLA-B27+ individuals, patients with various types of spondyloarthropathies (SpA), and with rheumatoid arthritis (RA) by CDR3-spectratyping. After collection and database submission of all available TCRB-CDR3 from HLA-B27-restricted or SpA-derived T cells, we systematically screened the entire human sequence database for sequences similar to the B27/SpA-related CDR3. Spectratyping revealed expanded T cell clones using conserved TCRBV1J2S3 in the SF from 5/6 of the patients with acute ReA but not among the controls. In database searches, 50 HLA-B27 or SpA-related CDR3-sequences generated similar clusters of matched sequences, and matched reciprocally. Identical or closely related sequences were identified in 15 different individuals and a canonical ReA-associated TCRB was defined [BV1-CASSVG(V/I/L)(Y/F)STDTQYF-J2S3]. All but one patient-derived conserved sequences originated from acute stage ReA-patients, and were not present among approximately 3800 other human TCRB sequences in the database. Five of the conserved sequences originated from T cell clones that recognized uninfected cells in an HLA-B27-restricted fashion, implying a role of HLA-B27-restricted CD8+ T cells specific for a ubiquitous self- or cross-reactive microbial determinant in the early phase of ReA. Related sequences were independently identified in four different laboratories. The consensus TCRB motif could be a helpful diagnostic marker in HLA-B27-associated 'undifferentiated arthritis'.
authors.affiliation: Department of Biology II, Ludwig Maximillans-Universität München, Munich, Germany. Ekhehard.May@lrz.uni-muenchen.de
authors.forename: E
authors.initials: E
authors.lastname: May
authors.forename: N
authors.initials: N
authors.lastname: Dulphy
authors.forename: E
authors.initials: E
authors.lastname: Frauendorf
authors.forename: R
authors.initials: R
authors.lastname: Duchmann
authors.forename: P
authors.initials: P
authors.lastname: Bowness
authors.forename: J A
authors.initials: JA
authors.lastname: Lopez de Castro
authors.forename: A
authors.initials: A
authors.lastname: Toubert
authors.forename: E
authors.initials: E
authors.lastname: Märker-Hermann
mesh_terms: D000328:Adult; D000368:Aged; D000595:Amino Acid Sequence; D016918:Arthritis, Reactive / Q000235:genetics* / Q000276:immunology / Q000473:pathology; D001324:Autoantigens / Q000276:immunology; D017124:Conserved Sequence; D030541:Databases, Genetic; D015796:HLA-B27 Antigen / Q000032:analysis*; D006801:Humans; D008875:Middle Aged; D008969:Molecular Sequence Data; D000091402:Prohibitins; D011948:Receptors, Antigen, T-Cell / Q000235:genetics; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000235:genetics* / Q000378:metabolism; D013167:Spondylitis, Ankylosing / Q000235:genetics / Q000473:pathology
chemical_list: D001324:Autoantigens; D015796:HLA-B27 Antigen; C000717331:PHB2 protein, human; D000091402:Prohibitins; D011948:Receptors, Antigen, T-Cell; D016693:Receptors, Antigen, T-Cell, alpha-beta